During the past decade, Sing Chan, MD conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sing Chan, MD" #1 sponsor was "Bristol-Myers Squibb" with 3 trials, followed by "Assembly Biosciences" with 2 trials sponsored, "Exact Sciences Corporation" with 2 trials sponsored, "Gilead Sciences" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Sing Chan, MD" are "Chronic Hepatitis B" (3 trials), "Colorectal Cancer" (2 trials), "HBV" (2 trials), "Hepatitis B, Chronic" (2 trials) and "Chronic HBV Infection" (1 trials). Many other conditions were trialed in "Sing Chan, MD" in a lesser frequency.

Most popular intervention types in "Sing Chan, MD" are "Drug" (8 trials), "Diagnostic Test" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Entecavir" (2 trials), "TAF" (2 trials), "TAF Placebo" (2 trials), "TDF" (2 trials) and "TDF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sing Chan, MD" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Sing Chan, MD". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Sing Chan, MD, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sing Chan, MD, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".